Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00750906 · ClinicalTrials.gov registry record
ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 13
- Enrollment target
NCT00750906 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 13 participants.
The verdict
NCT00750906 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This study will be conducted to determine the pharmacodynamics, cardiovascular and biochemical effects of succinylcholine when given during electroconvulsive therapy. (ECT). This is a single center, prospective, study in patients who will be receiving ECT as indicated and prescribed by their psychiatrist. The study will be performed twice on each patient, 48-72 hours apart during consecutively scheduled ECT procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-10 |
| Est. Completion | 2015-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00750906
The ClinicalTrials.gov registry entry for NCT00750906 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00750906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00750906 about?
NCT00750906 is a clinical study titled "ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes". This study will be conducted to determine the pharmacodynamics, cardiovascular and biochemical effects of succinylcholine when given during electroconvulsive therapy. (ECT). This is a single center, prospective, study in patients who will be receiving ECT as indicated and prescribed by their psychia...
What is the current status of trial NCT00750906?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2008-10. Estimated completion is 2015-04-30.
Who is sponsoring clinical trial NCT00750906?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.